SK Biopharmaceuticals financial statements

SK바이오팜KRX:326030 · KOSPI · Healthcare
₩75,700-1.30%
2026-10-02 close

SK Biopharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was KRW 547.6B. 2024 operating profit was KRW 96.34B.

Reported results

SK Biopharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q